Defense-Side Funding vs. Plaintiff-Side Funding

Defense-side funding suits a company facing litigation that wants to manage defense costs without a contingent recovery to repay from, typically structured as fee arrangements, portfolio defense programs, or monetization of counterclaims rather than a straightforward non-recourse advance against an affirmative claim. It is most relevant to companies facing recurring, high-volume litigation exposure rather than a single isolated matter.

Plaintiff-side funding suits a claimant or firm pursuing an affirmative claim for damages, where the funder's repayment is tied directly to a future recovery, the far more common and structurally simpler form of litigation finance because a clear, contingent asset — the claim itself — exists to price against. The large majority of the litigation finance market is built around this plaintiff-side structure.

Because a defendant has no recovery to repay a funder from, defense-side arrangements typically take other forms: fixed or capped-fee defense programs, financing structured against a viable counterclaim the defendant is separately pursuing, or portfolio arrangements across a company's docket of matters where predictable legal spend, not a contingent recovery, is what is being financed or managed. Each structure requires its own bespoke documentation rather than following a single standardized template.

A funder evaluates the claim's liability, damages, and collectability, then advances non-recourse capital repaid from case proceeds if the claim succeeds, a structure that works because the claim itself is the asset the funder's return is contingent upon. This is the well-established template used across the large majority of commercial and personal injury funding transactions.

Cost is typically structured as a fee, a portfolio-wide rate, or, where a counterclaim exists, a return contingent on that counterclaim's success, since there is no straightforward affirmative recovery on the defensive claim itself against which to price a contingent return. Pricing is negotiated individually given the absence of a standardized market benchmark for defense-side structures.

Cost is a return on capital calculated against the claim's expected recovery, paid only if the case succeeds, priced to compensate the funder for the risk that the claim fails and the funder recovers nothing. Established market conventions for plaintiff-side pricing give both funders and claimants a reasonably consistent benchmark to negotiate from.

Risk allocation on the defense side depends entirely on the specific structure used — a fixed-fee program shifts cost predictability risk to the provider, while a counterclaim-based structure carries the same contingent risk as any plaintiff-side funding, just applied to the counterclaim rather than the original claim against the company.

The funder bears the risk of losing its capital if the affirmative claim fails, a risk it manages through underwriting the claim's merits and diversifying across a portfolio of similarly structured investments.

Defense-side arrangements matter most for companies facing high-cost, unpredictable litigation exposure who want to manage that cost even without a contingent recovery, or who have a viable counterclaim worth financing on its own contingent terms. They are also useful for companies with a recurring pattern of similar claims, where a program-level solution is more efficient than negotiating each matter separately.

Plaintiff-side funding remains the more straightforward and far more common structure whenever a claimant has an affirmative claim capable of producing a recovery, since the claim itself provides the clear collateral a contingent funding arrangement is built around. Most claimants and firms exploring litigation finance for the first time will encounter this structure well before any defense-side variant.